Cencora (NYSE: COR)
Cencora Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Cencora Company Info
AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies. The Other segment focuses on global commercialization services and animal health, and includes AmerisourceBergen Consulting Services ABCS, World Courier, and MWI. The company was founded by in Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.
News & Analysis
3 Stocks to Buy as the Economy Recovers
These companies have been delivering strong results, and investors should expect that to continue next year.
Report: States Pushing for $26.4 Billion Settlement With Drug Companies Over Opioid Liability
Producer Johnson & Johnson, and distributors McKesson, AmerisourceBergen, and Cardinal Health will all be expected to contribute to the settlement.
Got $1,000? Buy These 3 Medical Distributor Stocks
These three companies dominate the industry, and all provide growth with a nice dividend.
Should You Own These 3 Healthcare Distributors?
These medication movers touch most of the prescriptions in the U.S. Are their stocks a buy?
Will a $48 Billion Global Settlement End U.S. Opioid Crisis Lawsuits?
A settlement in a closely watched Ohio case averted a federal trial and paves the way to a nationwide settlement -- if drug companies shorten their payment timelines.
Here's What You'll Want to Know About AmerisourceBergen's Third-Quarter Earnings Beat
The drug wholesaler kept its 2019 momentum going with solid revenue and earnings growth.
Here's What You Need to Know About AmerisourceBergen's Q2 Earnings Results
The big pharmaceutical distributor missed Wall Street's revenue estimate but delivered a strong earnings beat in Q2.
Why Lyft, PAR Technology, and AmerisourceBergen Slumped Today
Find out what drove these stocks lower.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.